About this Research Topic
We also welcome subtopics addressing, but not limited to:
- Neurodegenerative diseases (Parkinson's disease, Alzheimer's disease, dementia etc.)
- Prolonged disorders of consciousness (caused by trauma, stroke, hypoxic encephalopathy etc.)
- Mental diseases (depression, mutism, schizophrenia etc.)
We encourage:
- Defining typical indicators and emerging biomarkers of cognitive aging including epigenetic features of aging, such as the correlation between DNA methylation and aging, and the causal relationship with brain age, cognitive behavioral representations of aging, and degenerative neurological diseases
- Neuroimaging of aging, including MRI, PET, SPET and novel molecular imaging analysis methods
- Physical/sports exercise and its impact on cognitive function in aging populations
- Cognitive training programs and their effectiveness in improving cognitive abilities
- Other intervention techniques (e.g., DBS, TMS, TUS etc.) targeting cognitive enhancement in older adults
- Treatment strategies for cognitive impairments in patients (e.g., with neurodegenerative diseases, pDOC, depression etc.)
- Animal research elucidating the neurobiological mechanisms underlying cognitive aging
- Innovative experimental studies to evaluate cognition in animal models of normal aging, neurodegenerative diseases, and mental disorders
- Neuroscience research exploring the neural foundation of cognitive decline and resilience in aging
- Advanced technologies that help ameliorate age-related cognitive decline
Keywords: Neurocognitive Aging, Neurodegenerative Disorders, Intervention, Neuroimaging
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.